| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | 0.0043 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0027 | 0.9 |